Log in to search using one of your social media accounts:

 

Why you should only use antibiotics if truly necessary
Let’s be honest: most parents feel better when their sick child is prescribed an antibiotic. There’s just something so reassuring about having a prescription. It’s hard to feel like all you can do is wait and give your child TLC; it feels better to do something. Even when the doctor says that your child has a virus, and explains that antibiotics treat bacteria, not viruses, it’s common for parents to think: but what if there is even a little chance that there is a bacterial infection along with — or instead of — the virus? It can’t hurt to be safe, right? But that’s the thing...
Source: Thrive, Children's Hospital Boston - November 9, 2017 Category: Pediatrics Authors: Claire McCarthy Tags: Ask the Expert Health & Wellness antibiotics Claire McCarthy MD Source Type: news

After repeated C. diff infections, people change their behaviors
(Loyola University Health System) After suffering repeated bouts of debilitating Clostridium difficile infections, many patients significantly change their behaviors, but some precautions may do little to prevent future infections, according to a first-of-its-kind study. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 7, 2017 Category: Infectious Diseases Source Type: news

Outpatient antibiotics increase risk for C. difficile in the community
Research shows outpatient antibiotic use can increase a person's risk of developing " C. difficile " infection after discharge from the emergency room. (Source: Health News - UPI.com)
Source: Health News - UPI.com - October 26, 2017 Category: Consumer Health News Source Type: news

Outpatient antibiotics raise risk for acquiring C. difficile infection in the community
(Infectious Diseases Society of America) Outpatient antibiotic use is a primary risk factor for acquiring Clostridium difficile infection in the community, reinforcing the need for appropriate prescribing in this setting, a new study published in Open Forum Infectious Diseases confirms. The findings also suggest that a recent visit to the emergency department, independent of antibiotic use, may also be a risk factor for the infection, which can cause life-threatening diarrhea. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - October 26, 2017 Category: Infectious Diseases Source Type: news

Dental Antibiotics Could Be Adding to C difficile Cases Dental Antibiotics Could Be Adding to C difficile Cases
Conversations about stewardship have tended to focus on hospitals and leave out dentists. A study finds prescription information often is not being shared between medical and dental providers.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 16, 2017 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

HealthWatch: Antibiotics Linked To Superbug, Divorce May Be Genetic
BOSTON (CBS) – A new study links antibiotics prescribed by dentists to the superbug C. difficile. Minnesota health officials found almost 40 percent of dentists are not following guidelines and are overprescribing antibiotics. C. difficile is a serious intestinal infection but if patients get symptoms, they are more likely to call their doctors and not their dentist, so dentists aren’t necessarily seeing the bad outcomes. And while it’s completely appropriate for a dentist to prescribe an antibiotic for a dental infection, many are still prescribing them prophylactically to patients with certain heart con...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - October 9, 2017 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health Local News Syndicated Local Antibiotics C. difficile Divorce Dr. Mallika Marshall HealthWatch Source Type: news

Automation and Antimicrobial Stewardship Automation and Antimicrobial Stewardship
Want to know current rates of C difficile infection or nosocomial pneumonia? Information technology makes us'smarter and more efficient,'says Dr Lucas Schulz.Medscape Infectious Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 6, 2017 Category: Consumer Health News Tags: Infectious Diseases Article Source Type: news

Antibiotics for dental procedures linked to superbug infection, study shows
(Infectious Diseases Society of America) Dental procedures are an overlooked source of antibiotic prescribing, which is a concern as these medications increase the risk of developing C. difficile, according to an IDWeek study. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - October 6, 2017 Category: Infectious Diseases Source Type: news

The World Is Running Out of Much Needed New Antibiotics
Posters: Misuse of antibiotics and risks. Credit: WHOBy Baher KamalROME, Oct 4 2017 (IPS)The world is running out of new antibiotics to combat the growing threat of antimicrobial resistance, a new specialised report warns ahead of this year’s World Antibiotic Awareness Week, adding that most of the drugs currently in the clinical pipeline are modifications of existing classes of antibiotics and are only short-term solutions. The latest World Health Organization (WHO) report on this issue “Antibacterial agents in clinical development – an analysis of the antibacterial clinical development pipeline, includi...
Source: IPS Inter Press Service - Health - October 4, 2017 Category: International Medicine & Public Health Authors: Baher Kamal Tags: Featured Global Headlines Health Human Rights TerraViva United Nations Source Type: news

New study: Sepsis care initiatives may lead to higher C. difficile infection rates, antibiotic resistance
(Elsevier) Healthcare experts have long known the benefits of integrated sepsis care programs, yet less information has been published on potential unintended consequences of these programs. That's changed with a new study that suggests that electronic sepsis screenings and treatment protocols could, in fact, lead to increased use of certain broad-spectrum antibiotics and healthcare facility-onset (HCFO) C. difficile infection (CDI) rates, according to findings published in the October issue of the American Journal of Infection Control (AJIC). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 3, 2017 Category: International Medicine & Public Health Source Type: news

Is your poop the 'right stuff'? Then this Toronto hospital may want it to fight C. difficile
A Toronto medical team wants help saving C. difficile sufferers' lives, after they've run short on donors in their fecal transplant program. (Source: CBC | Health)
Source: CBC | Health - September 28, 2017 Category: Consumer Health News Tags: Radio/As It Happens Source Type: news

Paper of note in Science Translational Medicine 9 (406)
This week’s article describes how targeted antimicrobials may reduce the virulence of Clostridium difficile infection. (Source: Signal Transduction Knowledge Environment)
Source: Signal Transduction Knowledge Environment - September 12, 2017 Category: Science Authors: Ferrarelli, L. K. Tags: STKE Editors ' Choice Source Type: news

Summit Therapeutics secures $62m contract to develop ridinilazole for CDI treatment
UK-based drug discovery and development company Summit Therapeutics has secured a contract worth up to $62m to support the clinical and regulatory development of ridinilazole for the treatment of C. difficile infection (CDI). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 11, 2017 Category: Pharmaceuticals Source Type: news

Early Fecal Transplant Improves Survival After Severe C diff Infection Early Fecal Transplant Improves Survival After Severe C diff Infection
Patients with severe Clostridium difficile infection (CDI) who receive early fecal microbiota transplant (FMT) have improved survival, researchers from France report.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - September 7, 2017 Category: Surgery Tags: Gastroenterology News Source Type: news

BREAKTHROUGH as certain probiotics are found to produce powerful antibiotics that kill superbugs
(Natural News) Scientists at the Baylor College of Medicine are saying that next-generation probiotics can reduce the risk of becoming infected with the bacterium Clostridium difficile, also known a C. difficile or C. diff. This is a common bacterial infection which causes gastrointestinal issues such as bowel discomfort and diarrhea. Treatment for the condition usually... (Source: NaturalNews.com)
Source: NaturalNews.com - August 20, 2017 Category: Consumer Health News Source Type: news

Bezlotoxumab (Zinplava) for Prevention of Recurrent Clostridium Difficile Infection
The FDA has approved the fully human monoclonal antibody bezlotoxumab (Zinplava – Merck) for use with antibacterial drug treatment to reduce recurrence of Clostridium difficile infection (CDI) in adults with CDI at high risk for recurrence. It is the first drug to be approved for this indication. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - August 18, 2017 Category: Consumer Health News Source Type: news

Research opens possibility of reducing risk of gut bacterial infections with next-generation probiotic
(Baylor College of Medicine) In laboratory-grown bacterial communities, the co-administration of probiotic Lactobacillus reuteri and glycerol selectively killed C. difficile. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 9, 2017 Category: International Medicine & Public Health Source Type: news

Rebiotix starts enrolment in Phase III trial of RBX2660 for C. diff infection
US-based clinical-stage microbiome firm Rebiotix has started patient enrolment in a Phase III clinical trial of RBX2660 to prevent recurrent Clostridium difficile (C. diff) infection. (Source: Drug Development Technology)
Source: Drug Development Technology - August 8, 2017 Category: Pharmaceuticals Source Type: news

MassDevice.com +5 | The top 5 medtech stories for August 8, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Why the medtech contract manufacturing M&A trend isn’t slowing down Consolidation is increasingly shaping the medical device industry, but what about players on the other side of the fence? Medtech contract manufactur...
Source: Mass Device - August 8, 2017 Category: Medical Devices Authors: MassDevice Tags: Blog News Well Plus 5 Source Type: news

Luminex Corporation Receives FDA Clearance for ARIES C. difficile Assay
Sample to answer test provides detection of both toxin A and B AUSTIN, Texas, July 24, 2017 -- (Healthcare Sales & Marketing Network) -- Luminex Corporation (NASDAQ: LMNX) today announced that it has received FDA clearance for the ARIES® C. diffici... Diagnostics, FDA Luminex, ARIES, C. difficile Assay, C. difficile (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 24, 2017 Category: Pharmaceuticals Source Type: news

Medical News Today: Calcium could be the answer to C. difficile infection
Calcium is key in allowing Clostridium difficile to germinate, a new study finds, but it might also be the answer to stopping or slowing down its spread. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 14, 2017 Category: Consumer Health News Tags: Infectious Diseases / Bacteria / Viruses Source Type: news

Could calcium hold the key to fighting a dangerous hospital infection?
(Michigan Medicine - University of Michigan) It lurks in hospitals and nursing homes, preying upon patients already weak from disease or advanced age. It kills nearly 30,000 Americans a year, and sickens half a million more. But new research shows that Clostridium difficile bacteria can't do all this without enough of a humble nutrient: calcium. And that new knowledge may lead to better treatment for the most vulnerable patients. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 13, 2017 Category: Infectious Diseases Source Type: news

Health Watch: Sandbox Bacteria Warning
BOSTON (CBS) – It may not be all fun in the sun and sand this summer. That neighborhood sandbox may be a breeding ground for germs. A study out of Spain found that many of the playground sandboxes that they tested contained a bacterium which can cause a bad intestinal infection. The bacterium they were looking for in this small study is C. difficile which can cause a bad intestinal infection. Sandboxes could become contaminated through human and animal waste. Other studies have found parasites and worms in some sandboxes. Does this mean you shouldn’t let your children play in a sandbox? Not necessarily. But sta...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - July 10, 2017 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health Local News Children Health Health Watch playground sandbox Sandbox Bacteria Source Type: news

Recurring Gut Infections on the Rise: Study
Clostridium difficile is the No. 1 health care-linked infection in America, and some people can't shake it (Source: WebMD Health)
Source: WebMD Health - July 7, 2017 Category: Consumer Health News Source Type: news

Recurring Intestinal Infections on The Rise in U.S.: Study
Clostridium difficile is the No. 1 health care-linked infection in America, and some people can't shake it Source: HealthDay Related MedlinePlus Pages: Clostridium Difficile Infections, Diarrhea (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - July 7, 2017 Category: Consumer Health News Source Type: news

Recurring Intestinal Infections on the Rise in U.S.: Study
FRIDAY, July 7, 2017 -- Recurring Clostridium difficile intestinal infections are rising sharply in the United States, researchers warn. These infections sicken about 500,000 people a year, cause tens of thousands of deaths, and cost the U.S.... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 7, 2017 Category: General Medicine Source Type: news

Superbug that lurks sandpit found to contain C. difficile
Tests on sandpits found high levels of a superbug that poses a ‘serious threat’ to children, a study published in the journal Zoonoses and Public Health has found. (Source: the Mail online | Health)
Source: the Mail online | Health - July 7, 2017 Category: Consumer Health News Source Type: news

Clostridium difficile infection WARNING over children's sand pits harbouring superbug
SAND play pits harbour the emerging superbug C. diff that causes stomach upsets and diarrhoea and in rare cases damages the gut, a new study found. (Source: Daily Express - Health)
Source: Daily Express - Health - July 7, 2017 Category: Consumer Health News Source Type: news

Sand in public playgrounds may play a role in transmitting infections
(Wiley) Investigators have revealed that the Gram-positive, anaerobic bacterium Clostridium difficile is widely distributed in soil samples from children's and dogs' sandboxes located within the metropolitan area of Madrid. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 7, 2017 Category: International Medicine & Public Health Source Type: news

Multiply Recurrent C. difficile Infections Rising Sharply (FREE)
By Kelly Young Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM The incidence of multiply recurrent Clostridium difficile infections (CDI) increased faster than regular C. difficile infections in recent years, a study in … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - July 5, 2017 Category: Primary Care Source Type: news

Multiply Recurrent C difficile Infection Rates Sharply Rise Multiply Recurrent C difficile Infection Rates Sharply Rise
Multiply recurrent Clostridium difficile infection rates sharply rose from 2001 to 2012 compared with total C difficile rates.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 3, 2017 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Cases of recurrent Clostridium difficile infection are soaring
(University of Pennsylvania School of Medicine) Researchers from the Perelman School of Medicine at the University of Pennsylvania have found evidence that the most difficult C. difficile cases, known as multiple recurring C. difficile infections (mrCDI), are rapidly becoming more common. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 3, 2017 Category: International Medicine & Public Health Source Type: news

C. Diff Infections Are Falling, Thanks To Better Cleaning And Fewer Antibiotics
The bacterium C. difficile causes one of the most common infections in hospitals and nursing homes. After climbing for decades, the rate of new infections is now falling.(Image credit: David Phillips/Science Source) (Source: NPR Health and Science)
Source: NPR Health and Science - June 29, 2017 Category: Consumer Health News Authors: Angus Chen Source Type: news

Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis
This Meta-analysis (9,056,241 patient-days and 159 estimates of incidence ratios) found that antibiotic stewardship programmes reduced the incidence of infections and colonisation with multidrug-resistant bacteria and C difficile infections in hospital inpatients. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 20, 2017 Category: Consumer Health News Source Type: news

Association of Adverse Events With Antibiotic Use in Hospitalized Patients
In this study, a review of medical records of 1488 patients for 30 days after antibiotic (AB) initiation noted 298 (20%) experienced at least 1 AB-associated ADR. Also 56 (20%) non –clinically indicated AB regimens were associated with an ADR, including 7 cases of C difficile infection. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 20, 2017 Category: Consumer Health News Source Type: news

Preventing Recurrent CDI: New, Old, and Really Old Strategies Preventing Recurrent CDI: New, Old, and Really Old Strategies
Three new studies assess strategies for preventing recurrence of C difficile infection in patients at risk.Society for Healthcare Epidemiology of America (SHEA) (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 15, 2017 Category: Consumer Health News Tags: Infectious Diseases Viewpoint Source Type: news

Fecal transplants prevent diarrhea for up to two years
Researchers from the University of Alabama found all donated bacteria species persist in all recipients for at least six months. The procedure is approved for recurrent C.difficile infections.. (Source: the Mail online | Health)
Source: the Mail online | Health - June 14, 2017 Category: Consumer Health News Source Type: news

Donor microbes persist 2 years after fecal transplant to treat C. difficile infection
(University of Alabama at Birmingham) University of Alabama at Birmingham researchers have made the first direct demonstration that fecal donor microbes remained in recipients for months or years after a transplant to treat the diarrhea and colitis caused by recurrent Clostridium difficile infections -- a serious and stubborn cause of diarrhea after an antibiotic treatment for some other illness. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 13, 2017 Category: Infectious Diseases Source Type: news

Seres begins Phase III trial of SER-109 to treat recurrent C. difficile infection
US-based microbiome therapeutics developer Seres Therapeutics has begun a Phase III clinical trial of SER-109 for the treatment of patients suffering from multiple recurrent clostridium difficile (C. difficile) infection. (Source: Drug Development Technology)
Source: Drug Development Technology - June 12, 2017 Category: Pharmaceuticals Source Type: news

Antibiotic-Associated Adverse Events Common Antibiotic-Associated Adverse Events Common
As many as 20% of hospitalized patients prescribed antibiotics experienced an adverse drug event, including Clostridium difficile or multidrug-resistant organism infection, a new study found.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 12, 2017 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Preventing recurrence of Clostridium difficile infection: bezlotoxumab: Evidence summary [ES13]
This evidence summary discusses two similar randomised controlled trials that compared the efficacy and safety of a single dose of bezlotoxumab 10 mg/kg with placebo for preventing the recurrence of C difficile infection in people taking usual standard-of-care antibiotics (usually metronidazole or vancomycin). A summary to inform local decision-making is included. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 9, 2017 Category: Consumer Health News Source Type: news

C difficile Infection: An Orthopaedic Surgeon's Guide C difficile Infection: An Orthopaedic Surgeon's Guide
Find out what there is to know about the prevention and treatment strategies for this infection related to orthopedic procedures.Journal of the American Academy of Orthopaedic Surgeons (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 31, 2017 Category: Consumer Health News Tags: Orthopaedics Journal Article Source Type: news

Ridinilazole Versus Vancomycin for Initial C. Difficile Infection Ridinilazole Versus Vancomycin for Initial C. Difficile Infection
Ridinilazole, a novel, targeted-spectrum antimicrobial, was found to be non-inferior to vancomycin for treating initial Clostridium difficile infection (CDI), according to a study funded by the maker of ridinilazole (Summit Therapeutics, Abingdon, U.K.) and Wellcome Trust.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 24, 2017 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Optimal use of Rapid Diagnostics in Infection Control and Prevention
Clinical laboratories have implemented rapid diagnostic tests (RDTs) for the identification of bacterial pathogens, with subsequent improvements in antimicrobial stewardship, but these tests may also have a role in infection prevention. Early identification of pathogens by RDTs should allow faster implementation of infection prevention strategies with the goal of reducing transmission. In this review, we assess the use of RDTs as an infection control tool by exploring their role in screening, as well as diagnosis, of methicillin-resistant Staphylococcus aureus (MRSA), carbapenem-resistant gram-negative organisms, Clostridi...
Source: Clinical Microbiology Newsletter - May 20, 2017 Category: Microbiology Authors: Mary Elizabeth Sexton, Jesse T. Jacob Source Type: news

Clostridium difficile: To Test or Not to Test (and How?) Clostridium difficile: To Test or Not to Test (and How?)
New data help clinicians select appropriate patients for C diff testing.Society for Healthcare Epidemiology of America (SHEA) (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 18, 2017 Category: Consumer Health News Tags: Infectious Diseases Viewpoint Source Type: news

Can A 'Poop Transplant' Change Your Weight?
In this study, 70 patients received FMTs to treat C. diff infections. Twenty-five of the patients received stool from donors who had normal BMIs; 30 received stool from overweight donors, and 15 received stool from obese donors. [5 Ways Gut Bacteria Affect Your Health] In the six months before the transplants, many of the patients lost weight, which is common with C. diff infections, said lead study author Dr. Monika Fischer, a gastroenterologist and an assistant professor of clinical medicine at Indiana University School of Medicine. But in the year after the transplants, the researchers didn’t observe statistically...
Source: Healthy Living - The Huffington Post - May 16, 2017 Category: Consumer Health News Source Type: news

Synthetic Biologics ’ SYN-004 secures FDA breakthrough therapy status
Synthetic Biologics has secured breakthrough therapy designation for SYN-004 (ribaxamase) from the US Food and Drug Administration (FDA) to treat Clostridium difficile infection (CDI). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - May 14, 2017 Category: Pharmaceuticals Source Type: news

Maryland company wins FDA fast-track status for superbug drug
Rockville-based Synthetic Biologics Inc. received fast-track status from the Food and Drug Administration for a drug candidate that might prevent one of the most common health care-associated infections in the U.S. Clostridium difficile, often referred to as C. diff, sickens more than 450,000 patients in the U.S. every year and causes $1.5 billion in additional health care costs annually. The drug candidate SYN-004 is an oral enzyme designed to protect the gut microbiome against C. diff and the… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 12, 2017 Category: Pharmaceuticals Authors: Tina Reed Source Type: news

Maryland company wins FDA fast-track status for superbug drug
Rockville-based Synthetic Biologics Inc. received fast-track status from the Food and Drug Administration for a drug candidate that might prevent one of the most common health care-associated infections in the U.S. Clostridium difficile, often referred to as C. diff, sickens more than 450,000 patients in the U.S. every year and causes $1.5 billion in additional health care costs annually. The drug candidate SYN-004 is an oral enzyme designed to protect the gut microbiome against C. diff and the… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 12, 2017 Category: Biotechnology Authors: Tina Reed Source Type: news

This Rockville company just won breakthrough status for a drug to prevent hospital infection
Rockville-based Synthetic Biologics Inc. received fast-track status from the Food and Drug Administration for a drug candidate that might prevent one of the most common health care-associated infections in the U.S. Clostridium difficile, often referred to as C. diff, sickens more than 450,000 patients in the U.S. every year and causes $1.5 billion in additional health care costs annually. The drug candidate SYN-004 is an oral enzyme designed to protect the gut microbiome against C. diff and the… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 12, 2017 Category: Pharmaceuticals Authors: Tina Reed Source Type: news